ABVC icon

ABVC BioPharma

11 hedge funds and large institutions have $571K invested in ABVC BioPharma in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Holders
11
Holders Change
+6
Holders Change %
+120%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
2
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$330K 375,142
Geode Capital Management
2
Geode Capital Management
Massachusetts
$122K 139,653 +89,738 +180%
BlackRock
3
BlackRock
New York
$34K 38,665 -377 -1%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$25K 28,293 +28,293 New
Northern Trust
5
Northern Trust
Illinois
$16K 18,421 +18,421 New
TRCT
6
Tower Research Capital (TRC)
New York
$13K 15,098 +9,101 +152%
Citadel Advisors
7
Citadel Advisors
Florida
$11K 12,612 +12,612 New
Millennium Management
8
Millennium Management
New York
$10K 11,011 +11,011 New
Jane Street
9
Jane Street
New York
$10K 11,371 +11,371 New
AC
10
Armistice Capital
New York
-1,092,745 Closed
CFGS
11
Concourse Financial Group Securities
Alabama
Wells Fargo
12
Wells Fargo
California
$0 116 +116 New
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$0 239 +239 New